comparemela.com

Latest Breaking News On - Andera expansion - Page 1 : comparemela.com

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting

France generalNew yorkUnited statesBernard coulieLucy featherstoneAneta sottilJuliette audetLuc van rompaeyAndera croissanceWouter verhoevenBandera coGhent universityConsilium strategic communicationsWurzburg universityAndera life sciencesFountain healthcare partners

EQS-News: Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023

France generalRegion flamandeAndera croissanceAneta sottilBernard coulieWouter verhoevenLuc van rompaeyAndera life sciencesWurzburg universityMc servicesDistribution servicesGhent universityBandera coAndera partnersFountain healthcare partnersIndependent chairman

Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47 75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline

New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million Funds will be used to advance clinical

France generalUnited statesChristoph massnerPureos bioventuresOlivier litzkaMarie curieAndera croissanceLife sciencesAndera life sciencesBandera coAndera partnersEarlybird venture capitalAriceum therapeuticsAriceum boardChief executive officerSmall cell lung

EQS-News: Andera Partners co-leads a Series A extension round totalling € 47 75 million for radiopharmaceutical company Ariceum Therapeutics

EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics 18.04.2023 / 09:15 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE A.

France generalUnited statesMarie curieAndera croissancePureos bioventuresChristoph massnerOlivier litzkaBandera coAndera life sciencesLife sciencesMc servicesDistribution servicesAndera partnersAriceum therapeuticsEarlybird venture capitalAriceum board

EQS-News: Andera Partners leads $48 5 Million Series A financing for medical device company BioVentrix®

EQS-News: Andera Partners / Key word(s): Financing Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix® 13.04.2023 / 12:45 CET/CEST The issuer

United statesFrance generalBihua chenAndera croissanceRaphael wisniewskiJim dillonDrug administrationBioventrix incTaglich brothers incMc servicesAccess programDistribution servicesAndera life sciencesBandera coAndera partnersCormorant asset management

vimarsana © 2020. All Rights Reserved.